Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Role of lipoproteins and apolipoproteins in presentation of self lipid antigens by group 1 CD1 molecules and its significance in Multiple Sclerosis.

FY 2009-10

Summary
Multiple sclerosis (MS) is an inflammatory disease that affects our brain and spinal cord causing life-long debilitation. Canada has one of the highest rates of MS in the world and more than three Canadians are being diagnosed with MS every day. Current therapies only delay the progression of MS and there are no definitive cures yet. The cause of MS is unknown but there are a handful of studies suggesting that MS is caused by the immune system mistakenly attacking and eating away a protective covering called the myelin sheath that wraps around nerve cells. The myelin sheath is composed of 70% fat and 30% protein and it is thought that immune cells called T cells recognize the protein part of myelin as foreign and destroys it. Therapies aimed to alter immune response against myelin proteins have been developed but it has not lead to great success because MS patients responded differently to this therapy with some patients experiencing worsened MS. Therefore, diverse responses have limited the potential value of this therapy. Recently, researchers have discovered that T cells can recognize myelin fats and this elucidated the possibility that the fat portion of myelin may be the target of attack in MS. In addition, a study showed that immune response against fats is regulated by a fat transporter called apolipoprotein E (apoE) which has also been implicated in MS. The link between apoE's role in immune regulation and T cell's role in recognition of myelin fats will be very important in understanding how myelin fats become targets of attack. In this study, we will investigate whether immune attack against myelin fat plays any role in the cause of MS and if apoE or other fat transporters regulate this attack. This study will help better understand the mechanism of MS and lead to development of new therapies that targets this pathway. Drugs that alter fat metabolism may be promising for preventing attack against myelin and stopping disease progression
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
201572
Name
Kitano Naoki
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Role of lipoproteins and apolipoproteins in presentation of self lipid antigens by group 1 CD1 molecules and its significance in Multiple Sclerosis.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apolipoprotein; Autoimmunity; Elisa; Fast Protein Liquid Chromatography; Group 1 Cd1 Molecules; Lipids; Multiple Sclerosis; Myelin Antigens
Abstract
Multiple sclerosis (MS) is an inflammatory disease that affects our brain and spinal cord causing life-long debilitation. Canada has one of the highest rates of MS in the world and more than three Canadians are being diagnosed with MS every day. Current therapies only delay the progression of MS and there are no definitive cures yet. The cause of MS is unknown but there are a handful of studies suggesting that MS is caused by the immune system mistakenly attacking and eating away a protective covering called the myelin sheath that wraps around nerve cells. The myelin sheath is composed of 70% fat and 30% protein and it is thought that immune cells called T cells recognize the protein part of myelin as foreign and destroys it. Therapies aimed to alter immune response against myelin proteins have been developed but it has not lead to great success because MS patients responded differently to this therapy with some patients experiencing worsened MS. Therefore, diverse responses have limited the potential value of this therapy. Recently, researchers have discovered that T cells can recognize myelin fats and this elucidated the possibility that the fat portion of myelin may be the target of attack in MS. In addition, a study showed that immune response against fats is regulated by a fat transporter called apolipoprotein E (apoE) which has also been implicated in MS. The link between apoE's role in immune regulation and T cell's role in recognition of myelin fats will be very important in understanding how myelin fats become targets of attack. In this study, we will investigate whether immune attack against myelin fat plays any role in the cause of MS and if apoE or other fat transporters regulate this attack. This study will help better understand the mechanism of MS and lead to development of new therapies that targets this pathway. Drugs that alter fat metabolism may be promising for preventing attack against myelin and stopping disease progression
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kitano, Naoki
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~